Trials / Recruiting
RecruitingNCT06470607
The Lymphocytic Infiltrate of Lung Tumors.
Biological Observational Monocentric Study Aimed at Analyzing the Lymphocytic Infiltrate of Lung Tumors
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (estimated)
- Sponsor
- Scientific Institute San Raffaele · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is configured as a monocentric observational transversal biological study. The main objective of the study is the reconstruction of the molecular organization of tumors of the thoracic cavity, in particular non-small cell lung cancer (NSCLC). The study involves the collection of clinical data and biological material (blood and tumor tissue) from 70 subjects diagnosed with thoracic tumors.
Detailed description
Inclusion criteria: The study population will include all patients with the following characteristics: * Ability to provide informed consent * Men and women over the age of 18 years old * Patients candidates for surgical treatment diagnosed with thoracic tumors The procedures to which the patient will undergo during the study follow the standard of clinical practice for the treatment of pathology. Exclusion criteria: * Previous chemotherapy for any cancer within the last 6 months * Pregnant and/or breastfeeding women * Immunosuppressive state (states of immunosuppression or ongoing immunosuppressive/immunomodulatory treatments) The time of observation of the patient for the purposes of the study is limited to the time of hospitalization and the surgical procedure, the patient will therefore perform a single visit to the hospital and there is no provision for the collection of further data following discharge. The study involves a single timepoint of data collection and samples. The study will have a total duration of 3 years.
Conditions
Timeline
- Start date
- 2023-01-20
- Primary completion
- 2026-01-20
- Completion
- 2028-01-31
- First posted
- 2024-06-24
- Last updated
- 2024-11-29
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06470607. Inclusion in this directory is not an endorsement.